International Journal of Endocrinology / 2015 / Article / Tab 1

Research Article

Polymorphism in LEP and LEPR May Modify Leptin Levels and Represent Risk Factors for Thyroid Cancer

Table 1

Comparisons of different histopathological types according to their leptin serum expression.

Analysed groups Leptin

Malignant versus benign9.89 ± 0.63 versus 1.92 ± 0.69<0.001
CPTC versus goiter9.69 ± 0.89 versus 1.88 ± 0.73<0.001
CPTC versus FA9.69 ± 0.89 versus 2.11 ± 0.47<0.01
CPTC versus FC9.69 ± 0.89 versus 9.49 ± 0.50N.S.
FVPTC versus CPTC10.02 ± 0.57 versus 9.69 ± 0.89N.S.
FVPTC versus goiter10.02 ± 0.57 versus 1.88 ± 0.73<0.001
FVPTC versus FA10.02 ± 0.57 versus 2.11 ± 0.47<0.001
FVPTC versus FC10.02 ± 0.57 versus 9.49 ± 0.50N.S.
FC versus FA9.49 ± 0.50 versus 2.11 ± 0.47<0.001
FC versus goiter9.49 ± 0.50 versus 1.88 ± 0.73<0.01
FA versus goiter2.11 ± 0.47 versus 1.88 ± 0.73N.S.

CPTC: classic type PTC; FVPTC: follicular variant PTC; FC: follicular carcinoma; AF: follicular adenoma; N.S.: not statistically significant.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.